Fig. 1From: Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progressionThe flow chart of clinical study. Patients qualified with our study criteria were prospectively enrolled, with written informed consent obtained before any treatment. Included patients were allocated to two groups based on the average IHC C3 scoreBack to article page